J P Moulton Charitable Foundation

The J P Moulton Charitable Foundation, established in 2005 by British investor and philanthropist Jon Moulton, is a UK-registered charitable company dedicated to advancing health, saving lives, and relieving suffering through rigorous, evidence-based philanthropy. Chaired by Moulton with trustees including Dr Helen Critchley and Spencer Moulton, it prioritizes high-impact, non-commercial medical research addressing unmet clinical needs, such as clinical trials, translational science, and innovative therapies for serious diseases like Parkinson's and cardiovascular conditions. Its distinctive approach favors transformative, high-risk projects with clear patient benefits over commercial pursuits, exemplified by grants to the Cure Parkinson's Trust and the J Moulton Grant for AI-driven healthcare innovations administered via the BMA Foundation.

The foundation funds direct research costs for UK-based charities, academic institutions, NHS Trusts, and major research organizations engaged in clinical studies, disease prediction, management, and novel treatments. It supports medium to large established entities capable of delivering substantial impact, with a geographic focus exclusively on the UK, including collaborations across England, Wales, and beyond.

Grants typically range from £50,000 to £250,000, often multi-year, awarded adhoc at trustee meetings without fixed deadlines or open calls—unsolicited applications are not accepted, though written approaches may be considered on merit. Specific partner awards like the J Moulton Grant have deadlines (e.g., 16 March 2025). Exclusions include overheads, core costs, undergraduate/postgraduate education, travel, conferences, hardware, and unrestricted funding, underscoring its laser focus on pure research impact and operational integrity.